LILRB4 and Parkinson disease: This study aims to determine the association between LILRB4 polymorphism and PD clinical characteristics (e.g., typical motor and nonmotor functions) and PD pathological biomarkers (e.g., neuroimaging biomarkers and cerebrospinal fluid [CSF] biomarkers), thus clarifying the effect of LILRB4 on PD.